Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
ORD
Connection
HTTP/2
Language
Not provided

Ray ID: a46a96db8ce31923

Jump to content

// Workers AI · dad joke modeWhy did the Infectious Disease Research Institute go to therapy? It had a virus to work out.

Site of IDRI's facility in the Eastlake neighborhood of Seattle

The Infectious Disease Research Institute (IDRI) was a non-profit organization based in Seattle, in the United States, and which conducts global health research on infectious diseases. Its new name is Access to Advanced Health Institute (AAHI).

History

[edit]

IDRI was founded in 1993, by Steve Reed, PhD. [1]

Malaria vaccine

[edit]

IDRI is collaborating with the United States Agency for International Development to develop a malaria vaccine with the Walter Reed Army Institute of Research using Walter Reed's CelTOS malaria antigen in conjunction with IDRI's GLA-SE adjuvant.[2]

Visceral leishmaniasis vaccine

[edit]

In February 2012, IDRI launched the world's first clinical trial of the visceral leishmaniasis vaccine. The vaccine is a recombinant form of two fused Leishmania parasite proteins with an adjuvant. Two phase 1 clinical trials with healthy volunteers are to be conducted. The first one takes place in Washington and is followed by a trial in India. The trials are funded by the Bill & Melinda Gates Foundation.[3]

References

[edit]
  1. ↑ "Home". idri.org. Archived from the original on 2009-03-26. Retrieved 2011-09-12.
  2. ↑ Erica Teichert (18 August 2011). "USAID, IDRI form malaria vax collaboration". fiercevaccines.com. Archived from the original on November 9, 2011. Retrieved 12 September 2011.
  3. ↑ Elvidge, Suzanne (February 23, 2012). "World's first kala azar vaccine enters the clinic". FierceVaccines.com. Archived from the original on February 22, 2014. Retrieved March 1, 2012.
[edit]

47°38′3.1″N 122°19′28.7″W / 47.634194°N 122.324639°W / 47.634194; -122.324639